Long‐term efficacy of ustekinumab in patients with moderate‐to‐severe psoriasis treated for up to 5 years in the PHOENIX 1 study - Concepedia

Concepedia

Publication | Open Access

Long‐term efficacy of ustekinumab in patients with moderate‐to‐severe psoriasis treated for up to 5 years in the PHOENIX 1 study

DOI Full Paper Access

209

Citations

10

References

2012

Year

Alexa B. Kimball, Kim Papp, Yasmine Wasfi, Daphne Chan, Robert Bissonnette, Howard Sofen, Newman Yeilding, S. Li, Philippe Szapary, Kenneth B. Gordon

Journal of the European Academy of Dermatology and Venereology

Abstract

Through 5 years of continuous treatment, ustekinumab demonstrated stable clinical response and a safety profile consistent with previous reports.

References

	Year	Citations

Page 1